Semi-rational engineering of 3-Ketosteroid-Δ1-dehydrogenase boosts catalytic efficiency and robustness for steroid bioconversion
Enzyme and Microbial Technology · 2025
DOI: 10.1016/j.enzmictec.2025.110692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Enzyme and Microbial Technology, 2025. Verfasst von Zijuan Tao und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. Hauptthemen laut MEDLINE: Steroids, Oxidoreductases. Die Arbeit nennt 34 Literaturangaben. Gefördert von: 浙江工业大学, Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
Steroid drugs play a pivotal role in clinical therapeutics, with androsta-1,4-diene-3,17-dione (ADD) serving as a critical intermediate whose efficient biosynthesis relies on the catalytic activity of 3-ketosteroid-Δ1-dehydrogenase (KstD). Building upon the previously engineered KstD2ep variant, this study employed semi-rational design strategies to enhance KstD2's high-substrate-loading adaptability. Key residues (V332, L334, G534) were systematically identified through homology modeling and molecular docking, followed by constructing a combinatorial mutant library. Through alanine scanning and iterative screening of single/multiple-site mutations, the optimal mutant KstD2ep (V332E/L334T/G534V) demonstrated a 1.1-fold enhancement in catalytic efficiency compared to the KstD2ep. Molecular dynamics simulations confirmed significantly enhanced structural stability in the mutant. Whole-cell catalytic optimization revealed expanded operational tolerance to temperature fluctuations, pH variations, and co-solvent exposure. Implementing high-density fermentation coupled with fed-batch substrate supplementation, the process achieved a 1.5-fold increase in substrate conversion efficiency, yielding 117.75 g/L ADD. These advancements position the engineered variant as a high-potential candidate for scalable steroid biotransformation, addressing key barriers to enzymatic stability and process efficiency for enzyme-driven biosynthesis of steroidal pharmaceutical intermediates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China.
- Zhejiang Xianju Pharmaceutical CO., LTD, China.
- Department of Respiratory Medicine, The Third Affiliated Hospital of Qiqihar Medical College, Qiqihar, China.
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. Electronic address: oozzmm@163.com.
Förderung
- 浙江工业大学
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Tao, Z., Zhang, Y., Dai, Y., Huang, C., Luo, L., Yue, J., Yue, J., Shi, H., & Ou, Z. (2025). Semi-rational engineering of 3-Ketosteroid-Δ1-dehydrogenase boosts catalytic efficiency and robustness for steroid bioconversion. Enzyme and Microbial Technology. https://doi.org/10.1016/j.enzmictec.2025.110692
Vancouver
Tao Z, Zhang Y, Dai Y, Huang C, Luo L, Yue J, et al. Semi-rational engineering of 3-Ketosteroid-Δ1-dehydrogenase boosts catalytic efficiency and robustness for steroid bioconversion. Enzyme and Microbial Technology. 2025. doi:10.1016/j.enzmictec.2025.110692
BibTeX
@article{Tao2025,
author = {Tao, Zijuan and Zhang, Yusong and Dai, Yanmei and Huang, Changshun and Luo, Liangli and Yue, Junhao and Yue, Jing'e and Shi, Hanbing and Ou, Zhimin},
title = {Semi-rational engineering of 3-Ketosteroid-Δ1-dehydrogenase boosts catalytic efficiency and robustness for steroid bioconversion},
journal = {Enzyme and Microbial Technology},
year = {2025},
doi = {10.1016/j.enzmictec.2025.110692}
}
EUVIMED